These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27698008)

  • 21. Anaphylaxis to cisatracurium following negative skin testing.
    Fraser BA; Smart JA
    Anaesth Intensive Care; 2005 Dec; 33(6):816-9. PubMed ID: 16398392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M; Mok Q
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent anaphylactic reaction after induction with thiopentone and cisatracurium.
    Briassoulis G; Hatzis T; Mammi P; Alikatora A
    Paediatr Anaesth; 2000; 10(4):429-34. PubMed ID: 10886702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered Cisatracurium Pharmacokinetics and Pharmacodynamics in Patients with Congenital Heart Defects.
    Wu Z; Wang S; Peng X; Lu C; Ye X; Wu B
    Drug Metab Dispos; 2016 Jan; 44(1):75-82. PubMed ID: 26470914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagic Cell Death and Apoptosis Jointly Mediate Cisatracurium Besylate-Induced Cell Injury.
    Zhuang H; Tian W; Li W; Zhang X; Wang J; Yang Y; Liu X; Xia Z; Feng D; Zhang L
    Int J Mol Sci; 2016 Apr; 17(4):515. PubMed ID: 27058536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agreement between muscle movement and peripheral nerve stimulation in critically ill pediatric patients receiving neuromuscular blocking agents.
    Peña O; Prestjohn S; Guzzetta CE
    Heart Lung; 2000; 29(5):309-18. PubMed ID: 10986525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients.
    Lagneau F; D'honneur G; Plaud B; Mantz J; Gillart T; Duvaldestin P; Marty J; Clyti N; Pourriat JL
    Intensive Care Med; 2002 Dec; 28(12):1735-41. PubMed ID: 12447516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of cisatracurium besylate in vials, syringes, and infusion admixtures.
    Xu QA; Zhang YP; Trissel LA; Gilbert DL; Martinez JF; Fox JL
    Am J Health Syst Pharm; 1998 May; 55(10):1037-41. PubMed ID: 9606456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of cisatracurium in critical care: a review of the literature.
    Szakmany T; Woodhouse T
    Minerva Anestesiol; 2015 Apr; 81(4):450-60. PubMed ID: 24721895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass.
    Cammu G; Coddens J; Hendrickx J; Deloof T
    Br J Anaesth; 2000 May; 84(5):587-90. PubMed ID: 10844834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the efficacy of cisatracurium and atracurium in kidney transplantation operation.
    Jirasiritham S; Tantivitayatan K; Jirasiritham S
    J Med Assoc Thai; 2004 Jan; 87(1):73-9. PubMed ID: 14971538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate-type reactions to cisatracurium.
    Hunzelmann N; Kopner R; Hani N; Scharffetter-Kochanek K
    Allergy; 1999 Nov; 54(11):1227-8. PubMed ID: 10604564
    [No Abstract]   [Full Text] [Related]  

  • 35. Tachyphylaxis to cisatracurium--case reports and literature review.
    Haddad S
    Middle East J Anaesthesiol; 2008 Jun; 19(5):1079-92. PubMed ID: 18637607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisatracurium-induced neuromuscular block during total intravenous anaesthesia in a patient with Charcot-Marie-Tooth disease.
    Aceto P
    Eur J Anaesthesiol; 2010 Jul; 27(7):670-2. PubMed ID: 20179601
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia.
    Amin AM; Mohammad MY; Ibrahim MF
    Middle East J Anaesthesiol; 2009 Feb; 20(1):39-51. PubMed ID: 19266825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaphylactic reaction after cisatracurium.
    Clendenen SR; Harper JV; Wharen RE; Guarderas JC
    Anesthesiology; 1997 Sep; 87(3):690-2. PubMed ID: 9316977
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute coronary syndrome in cisatracurium-induced anaphylactic shock: Kounis syndrome.
    Yang YL; Huang HW; Yip HK; Jawan B; Tseng CC; Lu HF
    Acta Anaesthesiol Taiwan; 2008 Dec; 46(4):184-6. PubMed ID: 19097966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome.
    Riley K; Yampolsky N; Hakma Z; Moussouttas M
    Am J Health Syst Pharm; 2015 Apr; 72(8):632-5. PubMed ID: 25825186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.